References
- European Glaucoma SocietyTerminology and Guidelines for Glaucoma4th edItalySavona2104
- Kobelt-NguyenGGerdthamUGAlmACosts of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United StatesJ Glaucoma199872951049559495
- RobinALCovertDDoes adjunctive glaucoma therapy affect adherence to the initial primary therapy?Ophthalmology2005112586386815878067
- AnwarZWellikSRGalorAGlaucoma therapy and ocular surface disease: current literature and recommendationsCurr Opin Ophthalmol201324213614323542350
- LeungEWMedeirosFAWeinrebRNPrevalence of ocular surface disease in glaucoma patientsJ Glaucoma200817535035518703943
- HigginbothamEJConsiderations in glaucoma therapy: fixed combinations versus their component medicationsClin Ophthalmol201041920169043
- BarnebeyHSRobinALAdherence to fixed-combination versus unfixed travoprost 0.004%/timolol 0.5% for glaucoma or ocular hypertension: a randomized trialAm J Ophthalmol2017176616927993589
- HollóGTopouzisFFechtnerRDFixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practiceExpert Opin Pharmacother201415121737174724998246
- BarnebeyHSOrengo-NaniaSFlowersBEThe safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solutionAm J Ophthalmol200514011715990081
- CostaVPMoreiraHPaoleraMDde Moraes SilvaMREfficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapyClin Ophthalmol2012669970622654495
- SchumanJSKatzGJLewisRAEfficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertensionAm J Ophthalmol2005140224225016086946
- UusitaloHKähönenMRopoAImproved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucomaGraefes Arch Clin Exp Ophthalmol2006244111491149616628416
- UusitaloHNiñoJTahvanainenKEfficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogelActa Ophthalmol Scand200583672372816396651
- El Hajj MoussaWGFarhatRGNehmeJCComparison of efficacy and ocular surface disease index score between bimatoprost, latanoprost, travoprost, and tafluprost in glaucoma patientsJ Ophthalmol2018201817
- DelvalLBaudouinCGabissonPAlliotEVincentBDiamant Study GroupSafety and efficacy of unpreserved timolol 0.1% gel in patients controlled by preserved latanoprost with signs of ocular intoleranceJ Fr Ophtalmol201336431632323434331
- KonstasAGPMikropoulosDStewartWCFixed combination therapy in glaucomaShaarawyTSherwoodMHitchingsRCrowstonJGlaucomaPhiladelphiaElsevier20091566
- FrancisBADuLTBerkeSEhrenhausMMincklerDSCosopt Study GroupComparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol – a randomized controlled trial and a replacement studyJ Clin Pharm Ther200429437538015271105
- NucciCVaresiCMartucciAEfficacy of timolol 0.1% gel and a prostaglandin analog in an unfixed combination compared to the corresponding fixed combinationsEur J Ophthalmol201323568368923640513
- HughesBABacharachJCravenERA three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertensionJ Glaucoma200514539239916148589
- MetheetrairutALeumsamranPRojananinSKitnarongNA comparison of 0.1% timolol eye gel and 0.5% timolol eye drop in patients with chronic angle-closure glaucomaJ Med Assoc Thai201295Suppl 4S116S122
- KonstasAGMikropoulosDKaltsosKJenkinsJNStewartWC24-hour intraocular pressure control obtained with evening-versus morning-dosed travoprost in primary open-angle glaucomaOphthalmology2006113344645016513458